Endometrial volume and thickness measurements predict pituitary suppression and non-suppression during IVF

Human Reproduction

Volumn 17, Issue 12, 2002, Pages 3110-3113

  Child, Timothy J ^a   Sylvestre, Camille ^a   Tan, Seang Lin ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

3D ultrasound; Endometrial thickness; Endometrial volume; Pituitary suppression; Serum estradiol

Indexed keywords

BUSERELIN ACETATE; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; GONADORELIN AGONIST; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; BUSERELIN; GONADORELIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFECT; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYPOPHYSIS FUNCTION; MAJOR CLINICAL STUDY; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THICKNESS; THREE DIMENSIONAL IMAGING; TRANSVAGINAL ECHOGRAPHY; BLOOD; DRUG POTENTIATION; ECHOGRAPHY; HYPOPHYSIS; OVULATION INDUCTION; PHYSIOLOGY;

ADULT; BUSERELIN; ENDOMETRIUM; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVULATION INDUCTION; PITUITARY GLAND; ROC CURVE;

EID: 0036903821     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.12.3110     Document Type: Article

References (12)

1. Barash, A., Weissman, A., Manor, M., Milman, D., Ben-Arie, A. and Shoham, Z. (1998) Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program. Fertil. Steril., 69, 496-499.
2. Biljan, M.M., Mahutte, N.G., Dean, N., Hemmings, R., Bissonnette, F. and Tan, S.L. (1998) Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil. Steril., 70, 1063-1069.
3. Engmann, L., Maconochie, N., Bekir, J. and Tan, S.L. (1999a) Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: A prospective, randomized study. Am. J. Obstet. Gynecol., 181, 576-582.
4. Engmann, L., Sladkevicius, P., Agrawal, R., Bekir, J.S., Campbell, S. and Tan, S.L. (1999b) Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment. Fertil. Steril., 71, 22-29.
5. Hanley, J.A. and McNeil, B.J. (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148, 839-843.
6. Ibrahim, Z.H., Matson, P.L., Buck, P., Critchlow, J.D., Newman, M.C., Horne, G., Hughes, S. and Lieberman, B.A. (1990) Use of buserelin in an IVF programme for pituitary-ovarian suppression prior to ovarian stimulation with exogenous gonadotrophins. Hum. Reprod., 5, 258-262.
7. Kyei-Mensah, A., Maconochie, N., Zaidi, J., Pittrof, R., Campbell, S. and Tan, S.L. (1996) Transvaginal three-dimensional ultrasound: Reproducibility of ovarian and endometrial volume measurements. Fertil. Steril., 66, 718-722.
8. Nakamura, S., Douchi, T., Oki, T., Ijuin, H., Yamamoto, S. and Nagata, Y. (1996) Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding. Obstet. Gynecol., 87, 722-725.
9. Tan, S.L., Maconochie, N., Doyle, P., Campbell, S., Balen, A., Bekir, J., Brinsden, P., Edwards, R.G. and Jacobs, H.S. (1994) Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am. J. Obstet. Gynecol., 171, 513-520.
10. Templeton, A., and Morris, J.K. (1998) Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization. N. Engl. J. Med., 339, 573-577.
11. Yaman, C., Sommergruber, M., Ebner, T., Polz, W., Moser, M. and Tews, G. (1999) Reproducibility of transvaginal three-dimensional endometrial volume measurements during ovarian stimulation. Hum. Reprod., 14, 2604-2608.
12. Yaman, C., Ebner, T., Sommergruber, M., Hartl, J., Polz, W. and Tews, G. (2000) Three-dimensional endometrial volume estimation as a predictor of pituitary down-regulation in an IVF-embryo transfer programme. Hum. Reprod., 15, 1698-1702.